Our people are vital to our success

A team of experts

Our highly differentiated team members are experts at what they do. Our life sciences investment team members have deep technical scientific background, supplemented by strong commercial experience ranging from venture capital investment to pharmaceutical launch. This skill set has resulted in a strong network in life science, enabling the best talent to be attracted at the level of Syncona's portfolio companies. 

Attracting world-class talent

Working in close partnership with our portfolio company management teams is core to Syncona’s model.

An experienced and balanced board

Our fully independent board promotes a culture of openness and debate and exercises effective stewardship over the Company’s activities in the interests of all stakeholders.

The Syncona team

Please navigate below to see the members of the Syncona Investment Management Limited investment team, as well as key members of the Legal, Finance, IR and Corporate Affairs, and Support functions.

Martin Murphy

Martin Murphy

Chief Executive Officer
Chris Hollowood

Chris Hollowood

Chief Investment Officer
Markus John

Markus John

Chief Medical Officer and Head of R&D
Edward Hodgkin

Edward Hodgkin

Senior Partner
Elisa Petris

Elisa Petris

Lead Partner
Magdalena Jonikas

Magdalena Jonikas

Lead Partner
Alex Hamilton

Alex Hamilton

Investment Partner
Michael Kyriakides

Michael Kyriakides

Investment Partner
Gonzalo Garcia

Gonzalo Garcia

Investment Partner
Alice Renard

Alice Renard

Investment Partner
Raghd Rostom

Raghd Rostom

Associate Partner
Nathaniel Dahan

Nathaniel Dahan

Associate Partner
Lisa Bright

Lisa Bright

Commercial Advisor
Ben Woolven

Ben Woolven

Business Strategy and Operations Partner

Portfolio company teams

Syncona’s portfolio companies are led by world-class leaders. Please navigate below to see further information on the leaders of our portfolio companies, as well as their founders.